Molecular Biosafety

Abriouel H. , Franz C. & Ben Omar N. & Gálvez A. (2011). Diversity and applications of Bacillus bacteriocins. FEMS Microbiology Reviews, 35(1), 201–232.

Andrès E. & Dimarcq J. (2007). Cationic antimicrobial peptides: From innate immunity study to drug development. Médecine et Maladies Infectieuses, 37(4), 194–199. [Article in French]. Epub February 15, 2007.

Anisimov A. & Amoako K. (2006). Treatment of plague: Promising alternatives to antibiotics. Journal of Medical Microbiology, 55(Pt 11), 1461–1475.

Baron C. (2010). Antivirulence drugs to target bacterial secretion systems. Current Opinion in Microbiology, 13(1), 100–105. Epub January 14, 2010.

Bartfay W. & Bartfay E. & Green-Johnson J. (2011). Gram-negative and Gram-positive antibacterial properties of the whole plant extract of willow herb (Epilobium angustifolium). Biological Research for Nursing, January 5. [Epub ahead of print].

Bush K. (2010). Alarming β-lactamase-mediated resistance in multidrug-resistant Enterobacteriaceae. Current Opinion in Microbiology, 13(5), 558–564. Epub October 1, 2010.

Carson C. & Riley T. (2003). Non-antibiotic therapies for infectious diseases. Communicable Diseases Intelligence, 27 (Suppl), S143–146.

Clark J. & March J. (2006). Bacteriophages and biotechnology: Vaccines, gene therapy and antibacterials. Trends in Biotechnology, 24(5), 212–218. Epub March 29, 2006.

Courchesne N. & Parisien A. & Lan C. (2009). Production and application of bacteriophage and bacteriophage-encoded lysins. Recent Patents on Biotechnology, 3(1), 37–45.

Culos K. & Cannon J. & Grim S. (2011). Alternative agents to vancomycin for the treatment of methicillin-resistant Staphylococcus aureus infections. American Journal of Therapeutics, June 3. [Epub ahead of print].

Garcia P. , Martinez B. & Obeso J. & Rodriguez A. (2008). Bacteriophages and their application in food safety. Letters in Applied Microbiology, 47(6), 479–485.

Gould I. (2008). The epidemiology of antibiotic resistance. International Journal of Antimicrobial Agents, 32(Suppl 1), S2–9. Epub August 30, 2008.

Joerger R. (2003). Alternatives to antibiotics: Bacteriocins, antimicrobial peptides and bacteriophages. Poultry Science, 82(4), 640–647.

Lambert M. S. (2010a). Recombination and horizontal gene transfer: Routes to increased bacterial pathogenicity. Applied Biosafety: Journal of the American Biological Safety Association, 14(4), 200–201.

Lambert M. S. (2010b). Therapeutic potential and biosafety considerations regarding intrinsic immunity: A key component of mammalian protection against viruses. Applied Biosafety: Journal of the American Biological Safety Association, 15(2), 92–95.

Liu S. , Zhou L. , Lakshminarayanan R. & Beuerman R. , (2010). Multivalent antimicrobial peptides as therapeutics: Design principles and structural diversities. International Journal of Peptide Research and Therapeutics, 16(3), 199–213. Epub August 26, 2010.

Nguyen L. & Haney E. & Vogel H. (2011). The expanding scope of antimicrobial peptide structures and their modes of action. Trends in Biotechnology, June 14. [Epub ahead of print].

Oelschlaeger T. (2010). Mechanisms of probiotic actions—A review. International Journal of Medical Microbiology, 300 (1), 57–62. Epub September 23, 2009.

Parisien A. , Allain B. , Zhang J. & Mandeville R. & Lan C. (2008). Novel alternatives to antibiotics: Bacteriophages, bacterial cell wall hydrolases, and antimicrobial peptides. Journal of Applied Microbiology, 104(1), 1–13.

Poland G. (2011). Vaccines against Lyme disease: What happened and what lessons can we learn?. Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America, 52(Suppl 3), S253–258.

Quigley E. M. (2010). Prebiotics and probiotics; modifying and mining the microbiota. Pharmacological Research: The Official Journal of the Italian Pharmacological Society, 61(3), 213–218. Epub January 18, 2010.

Rotem S. & Mor A. (2009). Antimicrobial peptide mimics for improved therapeutic properties. Biochimica et Biophysica Acta, 1788(8), 1582–1592. Epub November 5, 2008.

Rozgony F. , Szabo D. , Kocsis B. , Ostorházi E. , Abbadessa G. & Cassone M. (2009). The antibacterial effect of a proline-rich antibacterial peptide A3-APO. Current Medicinal Chemistry, 16(30), 3996–4002.

Sang Y. & Blecha F. (2008). Antimicrobial peptides and bacteriocins: Alternatives to traditional antibiotics. Animal Health Research Reviews/Conference of Research Workers in Animal Diseases, 9(2), 227–235. Epub November 5, 2008.

Tanih N. F. , Dube C. , Green E. , Mkwetshana N. , Clarke A. M. & Ndip L. M. (2009). An African perspective on Helicobacter pylori: Prevalence of human infection, drug resistance, and alternative approaches to treatment. Annals of Tropical Medicine and Parasitology, 103(3), 189–204.

Tew G. , Scott R. & Klein M. & Degrado W. (2010). De novo design of antimicrobial polymers, foldamers, and small molecules: From discovery to practical applications. Accounts of Chemical Research, 43(1), 30–39.

Viazis S. , Akhtar M. & Feirtag J. & Diez-Gonzalez F. (2011). Reduction of Escherichia coli O157:H7 viability on hard surfaces by treatment with a bacteriophage mixture. International Journal of Food Microbiology, 145(1), 37–42. Epub November 22, 2010.